| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,581 |
4,227 |
$165K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,538 |
2,136 |
$137K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,461 |
2,172 |
$129K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,391 |
1,159 |
$97K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
403 |
337 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,388 |
1,159 |
$69K |
| 87634 |
|
1,370 |
1,153 |
$69K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
789 |
684 |
$52K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,363 |
1,163 |
$51K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,408 |
1,185 |
$48K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
872 |
754 |
$45K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,064 |
892 |
$33K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
496 |
405 |
$31K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
496 |
405 |
$31K |
| 87563 |
|
464 |
377 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
166 |
135 |
$16K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
513 |
398 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
435 |
428 |
$11K |
| 94760 |
|
2,607 |
2,305 |
$8K |
| 87511 |
|
217 |
191 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
149 |
114 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
49 |
41 |
$4K |
| 80074 |
|
118 |
88 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
36 |
32 |
$4K |
| 99384 |
|
32 |
32 |
$3K |
| 81025 |
|
575 |
457 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
128 |
121 |
$3K |
| 87641 |
|
65 |
50 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
29 |
29 |
$2K |
| 87500 |
|
70 |
51 |
$2K |
| 87640 |
|
58 |
48 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
26 |
17 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
19 |
19 |
$2K |
| 99383 |
|
14 |
14 |
$1K |
| 81002 |
|
490 |
400 |
$1K |
| 81003 |
|
453 |
380 |
$952.11 |
| 86696 |
|
45 |
38 |
$842.58 |
| 87480 |
|
35 |
16 |
$701.75 |
| 87510 |
|
35 |
16 |
$701.75 |
| 86695 |
|
45 |
38 |
$589.64 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
17 |
17 |
$425.00 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
44 |
26 |
$356.70 |
| 80053 |
Comprehensive metabolic panel |
36 |
24 |
$326.74 |
| 86592 |
|
60 |
41 |
$231.89 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
16 |
14 |
$166.77 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23 |
12 |
$132.02 |
| 82947 |
|
14 |
13 |
$51.57 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
461 |
343 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
237 |
185 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
34 |
26 |
$0.00 |